Medicago sativa / Luzerne

Alfalfa, luzerne of Medicago sativa

Alfalfa, luzerne, medicago sativa. Een klaverplant die op verschillende manieren gebruikt wordt. De gedroogde groene plant als veevoer en als versterkend middel voor de mens, de gekiemde zaden bekend onder de naam alfalfa als gezondheidsvoedsel in salades en op de boterham en ook de zaadjes zelf zijn gemalen als voedingsupplement te gebruiken.

Etymologie van luzerne

Het woord 'luzerne' kan etymologisch op vele manieren verklaard worden. 'Lucerna' komt volgens sommige bronnen van het Latijn voor 'lamp' en zou dan verwijzen naar de heldere zaden van de plant of naar 'lucerno', glimworm. Andere bronnen vermelden dat het de naam 'luzerne' kreeg naar de Zwitserse plaats Luzern, waar het op de kalkrijke gronden goed gedijde, nog andere beweren dat het komt van 'lucre' = 'winst' en dat het slaat op de verhoogde melkgift bij vee door het eten van luzerne. Als diervoeding is het in elk geval ook nu nog populair.

Voor 'medicago' zijn er eveneens verschillende verklaringen: 'kruid van Media', een stad waar de de Meden vandaan kwamen of van 'medica', 'geneeskrachtig', of nog van 'medik', en wijst op de stad Medea, in Noord-Afrika.

'Alfalfa' is de Spaanse vorm van het Arabische 'al-fac-facah', wat 'vader van alle voedsel' betekent. Andere namen: alfalfa, buffalogras, eeuwige klaver, hanenkammetjes, hoge klaver, koegras, luzerne, rupsklaver, zevenjarige klaver

Inhoudstoffen van Medicago sativa (groene plant)

Alkaloïden (asparagine, trigonelline), cumarine, vitaminen, mineralen, fyto-oestrogenen (formometin, coumestrol), proteïnen incl. canaranine (amino acid), enzymen

Tonicum: algemeen versterkend

De gehele groene plant werkt algemeen versterkend. Luzerne en alfalfa zijn een stimulans, ze werken vitaliserend, opbouwend, ze zijn een tonicum voor de hypofyse en de schildklier, ze verhogen de TRH = thyreotropine releasing hormone, door het complex van vitaminen, mineralen en aminozuren. Dus: gebruik luzerne en alfalfa bij vermoeidheid, lusteloosheid, zwakte, energieverlies, prestatiezwakte, geheugenzwakte, geestelijke vermoeidheid en verminderde alertheid.

Het kruid werkt remineraliserend en opbouwend. Het is versterkend op huid, haar, nagels, kraakbeen en beenderen doordat er vitamines, mineralen, aminozuren en chlorofyl aanwezig zijn die de weefselgroei stimuleren.

De plant heeft ook een hoge voedingswaarde en bevordert daarbij ook nog de opname van mineralen, eiwitten en andere voedingsstoffen. Ze bevordert ook de melkproductie. Maak er gebruik van bij een verhoogde behoefte aan mineralen en vitaminen bijvoorbeeld voor kinderen in de groei, bij intensief sporten en als je zware inspanningen moet leveren.

Hormonaal: in de overgang

Luzerne en alfalfa remmen botafbraak na de menopauze door de aanwezige fyto-oestrogenen. Je kan de plant dus gebruiken bij slappe huid, bij wonden, bij afbrekende en gespleten haren, bij broze nagels. Ze is nuttig bij osteoporose, bij zwakke beenderen en bij kraakbeenslijtage. Ze regelt de vrouwelijke hormonen en is ze menstruatiebevorderend door de fyto-oestrogenen genisteïne, biocanine en coumestral en door de mineralenrijkdom. Gebruik ze dus bij menopauzale klachten: opvliegers, nachtzweten, vaginale droogte, postmenopauzale osteoporose, uitblijvende menstruatie, bij te hoge of te lage oestrogeenspiegel.

Cholesterolverlagend

Zijn cholesterolverlagende werking is nog het best wetenschappelijk onderbouwd. De kritische Natural Standard vermeldt o.a. dat 'Multiple animal studies have demonstrated cholesterol-lowering and triglyceride-lowering effects of alfalfa, possibly without effects on high-density lipoprotein (HDL). Saponins in alfalfa may decrease intestinal absorption and increase fecal excretion of cholesterol'.

Nog veel meer werkingen worden vermeld zoals bloedsuikerverlagend (suikerziekte), immuunmodulerend en schimmelwerend. toch lijken mij de belangrijkste toepassingen: bij zwakte, gebrek aan energie, in de overgang en bij een te hoog cholesterol.

Alfalfa (Medicago sativa) based on Natural Database

Alfalfa is a legume that has a long history of dietary and medicinal uses. A small number of animal and preliminary human studies report that alfalfa supplements may lower blood levels of cholesterol and glucose. However, most research has not been well-designed. Therefore, there is not enough reliable evidence available to form clear conclusions in these areas.

Alfalfa supplements taken by mouth appear to be generally well tolerated. However, ingestion of alfalfa tablets has been associated with reports of a lupus-like syndrome or lupus flares. These reactions may be due to the amino acid L-canavanine, which appears to be present in alfalfa seeds and sprouts, but not in the leaves. There are also rare cases of pancytopenia (low blood counts), dermatitis (skin inflammation), and gastrointestinal upset.

Scientific Evidence

Uses

Atherosclerosis (cholesterol plaques in heart arteries) C grade

Several studies in animals report reductions in cholesterol plaques of the arteries after use of alfalfa. Well-designed research in humans is necessary before a firm conclusion can be drawn.

Diabetes C grade

A small number of animal studies report reductions in blood sugar levels following ingestion of alfalfa. Human data are limited, and it remains unclear if alfalfa can aid in the control of sugars in patients with diabetes or hyperglycemia.

High cholesterol C

Reductions in blood levels of total cholesterol and low-density lipoprotein ("bad cholesterol") have been reported in animal studies and in a small number of human cases. High-density lipoprotein ("good cholesterol") has not been altered in these cases. Although this evidence is promising, better research is needed before a firm conclusion can be reached.

*Key to grades:

A: Strong scientific evidence for this use;

B: Good scientific evidence for this use;

C: Unclear scientific evidence for this use;

D: Fair scientific evidence against this use (it may not work);

F: Strong scientific evidence against this use (it likely does not work).

Tradition

Allergies, antifungal, antimicrobial, antioxidant, appetite stimulant, asthma, bladder disorders, blood clotting disorders, boils, breast cancer, cervical cancer, cough, diuresis (increased urination), estrogen replacement, gastrointestinal tract disorders, gum healing after dental procedures, increasing breast milk, indigestion, inflammation, insect bites, jaundice, kidney disorders, menopausal symptoms, nutritional support, peptic ulcer disease, prostate disorders, radiotherapy induced skin damage, rheumatoid arthritis, scurvy, skin damage from radiation, stomach ulcers, thrombocytopenic purpura, uterine stimulant, vitamin supplementation (vitamins A,C,E,K), wound healing.

Dosing

Adults (18 years and older)

  • A dose of 5-10 grams of dried herb three times daily has been taken by mouth.

  • Two tablets (1 gram each) of Cholestaid® (esterin processed alfalfa) taken by mouth three times daily for up to two months, then 1 tablet three times daily, has been recommended by the manufacturer.

  • A dose of 5 to 10 milliliters (one to two teaspoonfuls) of a 1:1 solution in 25% alcohol three times daily has been taken by mouth.

  • For treating high cholesterol, 40 grams of heated seeds prepared three times daily with food has been taken by mouth.

Children (younger than 18 years)

Alfalfa supplements in children are not recommended due to potential side effects.

References

Anon. From the Centers for Disease Control and Prevention. Outbreaks of Escherichia coli O157:H7 infection associated with eating alfalfa sprouts--Michigan and Virginia, June-July 1997. JAMA 9-10-1997;278(10):809-810. View Abstract

Bengtsson AA, Rylander L, Hagmar L, et al. Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford) 2002;41(5):563-571. View Abstract

Boue SM, Wiese TE, Nehls S, et al. Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. J Agric Food Chem 4-9-2003;51(8):2193-2199. View Abstract

Burden and causes of foodborne disease in Australia: Annual report of the OzFoodNet network, 2005. Commun Dis Intell 2006;30(3):278-300. View Abstract

Farnsworth NR. Alfalfa pills and autoimmune diseases. Am J Clin Nutr 1995;62(5):1026-1028. View Abstract

Hwang J, Hodis HN, Sevanian A. Soy and alfalfa phytoestrogen extracts become potent low-density lipoprotein antioxidants in the presence of acerola cherry extract. J Agric Food Chem 2001;49(1):308-314. View Abstract

Lanza A, Tava A, Catalano M, et al. Effects of the Medicago scutellata trypsin inhibitor (MsTI) on cisplatin-induced cytotoxicity in human breast and cervical cancer cells. Anticancer Res 2004;24(1):227-233. View Abstract

Malinow MR, McLaughlin P, Naito HK, et al. Regression of atherosclerosis during cholesterol feeding in Macaca fascicularis. Am J Cardiol 1978;41:396.

Malinow MR, McLaughlin P, Naito HK, et al. Effect of alfalfa meal on shrinkage (regression) of atherosclerotic plaques during cholesterol feeding in monkeys. Atherosclerosis 1978;30(1):27-43. View Abstract

Malinow MR, McLaughlin P, Stafford C. Alfalfa seeds: effects on cholesterol metabolism. Experientia 5-15-1980;36(5):562-564. View Abstract

Malinow MR, Bardana EJ Jr, Goodnight SH Jr. Pancytopenia during ingestion of alfalfa seeds. Lancet 3-14-1981;1(8220 Pt 1):615. View Abstract

Molgaard J, von Schenck H, Olsson AG. Alfalfa seeds lower low density lipoprotein cholesterol and apolipoprotein B concentrations in patients with type II hyperlipoproteinemia. Atherosclerosis 1987;65(1-2):173-179. View Abstract

Srinivasan SR, Patton D, Radhakrishnamurthy B, et al. Lipid changes in atherosclerotic aortas of Macaca fascicularis after various regression regimens. Atherosclerosis 1980;37(4):591-601. View Abstract

Swanston-Flatt SK, Day C, Bailey CJ, et al. Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia 1990;33(8):462-464. View Abstract

Van Beneden CA, Keene WE, Strang RA, et al. Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts. JAMA 1-13-1999;281(2):158-162. View Abstract

Pharmaceutical Biology Volume 49, Issue 2, 2011

Phytochemical and pharmacological potential of Medicago sativa: A review

DOI:10.3109/13880209.2010.504732

Kundan Singh Bora*a & Anupam Sharmab

pages 211-220 Published online: 25 Oct 2010

Context: Many herbal remedies have so far been employed for the treatment and management of various ailments since the beginning of human civilization. Medicago is an extensive genus of the family Leguminosae, comprising about 83 different species. Medicago sativa (Linn.) has long been used as traditional herbal medicine in China, Iraq, Turkey, India and America for the treatment of a variety of ailments.

Objectives: The aim of this review was to collect all available scientific literature published and combine it into this review. The present review comprises the ethnopharmacological, phytochemical and therapeutic potential of M. sativa.

Methods: The present review includes 117 references compiled from major databases as Chemical Abstracts, Science Direct, SciFinder, PubMed, Dr. Dukes Phytochemical and Ethnobotany, CIMER, and InteliHealth.

Results: An exhaustive survey of literature revealed that saponins, flavonoids, phytoestrogens, coumarins, alkaloids, amino acids, phytosterols, vitamins, digestive enzymes and terpenes constitute major classes of phytoconstituents of this plant. Pharmacological reports revealed that it is used as neuroprotective, hypocholesterolemic, antioxidant, antiulcer, antimicrobial, hypolipidemic, estrogenic, and in the treatment of atherosclerosis, heart disease, stroke, cancer, diabetes and menopausal symptoms in women.

Conclusion: M. sativa seems to hold great potential for in-depth investigation for various biological activities, especially their effects on central nervous and cardiovascular system. Through this review, the authors hope to attract the attention of natural product researchers throughout the world to focus on the unexplored potential of M. sativa, and it may be useful in developing new formulations with more therapeutic value.

Research Medicago sativa

    • Scientific research confirms the effectiveness of Medicago sativa as a natural treatment for high cholesterol. It is known to reduce low-density lipoproteins (LDL, or bad cholesterol) without reducing high-density lipoproteins (HDL, or good cholesterol).

    • Studies have shown that alfalfa may reduce blood sugar levels due to its high manganese content. Clinical studies have shown that Medicago sativa with a high level of manganese improved the condition of diabetic patients who do not respond to insulin.

    • The plant contains a molecule analog to the thyrotropin-releasing hormone (TRH). Thyrotropin-releasing hormone is common in the animal kingdom but unknown in the vegetable kingdom.

    • The TRH hormone analog found in alfalfa is also biologically active in animals, suggesting that Medicago sativa may be an effective natural therapy for treating secondary hypothyroidism as well as diseases caused by an excess of prolactin, as in polycystic ovaries.

    • Scientific studies indicate that Medicago sativa may have a stimulating effect on the immune system.

    • Alfalfa has been shown to inhibit the development of certain viruses, including herpes simplex virus.

    • Some in vitro studies have shown that L-canaverina present in the herb has anti-tumor actions against certain types of leukemia in mice and a selective toxicity against cancer cells in dogs.

Active Ingredient and Substances

The active components include up to 50 percent protein, beta-carotene, chlorophyll, octacosanol, saponins, sterols, flavonoids, coumarins, alkaloids, acids,

The plant also contains vitamins (A, B, B6, B12, C, D, E, K, niacin, pantothenic acid, biotin, folic acid), amino acids, sugars, minerals (Ca, K, P, Ma, Fe, Zn, Cu), and trace elements.

Plant Parts Used

The stems, leaves, and flowers of alfalfa are used in herbal medicine.

The plant is generally collected before flowering and dried for later use in herbal medicinal preparations such as capsules, tablets, extracts or extracts (infusions).

Dosage and Administration

The usual dose of alfalfa leaves for tea is 1 to 2 teaspoons per cup, steeped for 10 to 20 minutes.

Powdered alfalfa is widely available in powder form where the manufacturer’s recommendations should then be followed.

For cholesterol reduction, the recommended dosage is 5 to 10 grams of dried alfalfa leaves, taken three times a day.

Possible Side Effects and Interactions of Alfalfa

    • The biggest risk in using alfalfa is eating sprouts grown in contaminated water or sprouts that have gone bad and are decomposing.

    • For most people, alfalfa is safe, but it may interact with certain medications.

    • Those who are taking anti-rejection drugs for transplant, should not use any form of alfalfa.

    • People who take Coumadin or other anticoagulant drugs should consult with their physicians concerning what amounts of green vegetables (which contain high amounts of vitamin K) are safe to consume.

    • Eating the sprouts have been linked to systemic lupus erythematosus (SLE). Those diagnosed with SLE should avoid alfalfa products.

    • Consuming large amounts of the seeds has also caused reversible blood abnormalities.

    • In rare instances of excessive consumption of alfalfa herb or sprouts, abnormal red blood cell counts, enlargement of the spleen or relapses of lupus may occur.